CoVID-19 Solutions
In keeping with our commitment to provide innovative health solutions Luminnova Health has responded to the CoVID-19 outbreak with the following initiatives:
Prevention Initiatives
A selection of effective, affordable CoVID-19 infection control measures available through our Luminnova Health Store
Treatment Initiatives
Background
The foundation of these prevention and treatment initiatives is a clinical study sponsored by the North Rhine-Westphalia state government in Germany. This study was highly successful. However, in view of the highly contagious nature of CoVID-19 infection, the Luminnova Health CoVID-19 Home Care Program was developed.
An Urgently Needed Treatment
We are pleased to announce that we have CoVID-19 treatment options available which are:
Effective
Safe and
Affordable
The Medlouxx PPR treatment converts CoVID-19 infection from a potentially debilitating and deadly disease to a relatively mild illness of short duration. It involves a single session using a patented non-invasive Medlouxx PPR phototherapy device and a photosensitizing agent. The photosensitizer – methylene blue – has a long history of use with numerous studies showing it to be very safe for use. Overall, the treatment is very affordable and easy to administer. During the treatment, the virus is immediately inactivated in the nose and mouth which are the target treatment areas.
The Medlouxx device is approved in Europe and we are extremely happy to report that we recently received an official endorsement of efficacy of the treatment from the regional government of North Rhine-Westphalia in Germany, which sponsored the CoVID-19 clinical study of 1200 subjects. As a result of the overwhelmingly positive response to the treatment, including a ten fold reduction in death rate, the treatment will be officially adopted in Germany. We also anticipate full adoption of this safe and highly effective approach throughout Europe and beyond in the near future.
Benefits of Medlouxx Treatments
The Medlouxx PPR treatment significantly increases the likelihood of a mild course of illness from CoVID-19 by essentially eradicating the virus before it has had a chance to spread from the initial site of infection to the lungs and other organs. The primary benefit of the treatment is to dramatically reduce the need for hospitalization, ICU admission and death due to CoVID-19 infection. This benefit is observed even in the elderly and in individuals at greater risk due to co-morbidities.
Perhaps of even greater importance from a public health perspective, another major benefit is that the Medlouxx PPR protocol promises to break the cycle of transmission by immediately eliminating viral load from the nose and mouth (the main source of infectious viral droplets). We are confident that this solution can reduce the heavy toll on our healthcare systems and facilitate the safe re-opening of our economies.
We believe Medlouxx PPR also has significant potential for treating other respiratory infections including influenza, so this protocol will offer benefits well into the future.
Medlouxx PPR Results
The treatment involves a medically recognized approach referred to as antimicrobial photodynamic therapy (aPDT). Blood banks have long relied on this rapidly effective technique to eradicate viruses and other dangerous pathogens from blood prior to transfusion. A similar approach was shown to be highly effective against CoVID-19 in a controlled clinical study of 1200 subjects. In view of the staggering CoVID-19 toll and the promising results obtained, we published an interim study report in the American Journal of Virology and Disease in May 2020. This interim report demonstrated statistically significant results at only half the projected sample size:
an 83% reduction in hospital admissions,
90% reduction in ICU admissions and
80% reduction in the death rate.
Imagine what a difference this treatment can make to the healthcare system, families impacted by this horrible disease and the ability to resume normal business activity!
Medlouxx PPR Treatment Protocol
A single treatment session is administered. Any viral load present in the nose or oral cavity is immediately eradicated by the treatment. This protects the patient as well as anyone with whom they come into contact. Treatments take 15 to 30 minutes, are well tolerated and SAFE for patients of all ages. The device used is fully portable and fits into a small, lightweight briefcase:
CoVID-19 Interim Study Highlights
American Journal of Virology and Disease
Our recently published study clearly shows that CoVID-19 can be effectively treated, if treatment is administered at the early stages of infection.
The study, conducted by Dr. Detlef Schikora in Germany reports on 600 patients: 300 patients who received the active treatment protocols and 300 who were control subjects
The full study of 1200 subjects was completed in November 2020.
The aim of the treatment was to convert CoVID-19 from a devastating infection to a mild infection that resolves quickly without the need for hospital admission.
We observed that almost twice as many patients that were treated only had a mild fever lasting for a week or less, compared to those who didn’t receive treatment. It’s very important to note these mild symptoms were observed across all ages, including the elderly and those with other medical conditions.
The definition of mild symptoms: mild fever which lasted for a maximum of 1 week.
There was an 83% reduction in hospital admissions and 91% reduction in ICU admissions
The death rate was 5 times LOWER in the active treatment subjects
Treatment was provided to patients with confirmed PCR CoVID-19 tests, in the early stages of infection. This innovative protocol focused on reducing the viral load in both the oral cavity (mouth) and nose and throat with photodynamic viral inactivation.
Formation of specific CoVID-19 antibodies was confirmed in 96% of actively treated subjects.
There were no known treatment related adverse events.
This is an important breakthrough!! We now have a treatment available which is truly effective, but at the same time is very safe.
What is photodynamic Viral inactivation?
Photodynamic inactivation uses specific wavelengths of light to activate special compounds that leads to the formation of reactive oxygen species which can literally render the CoVID-19 virus powerless. It’s not a new concept but this is the first large scale peer reviewed human study to clearly demonstrate this effect, and certainly the first to show that CoVID-19 can be treated effectively in human subjects using antimicrobial photodynamic inactivation.
For more information contact us through this website or at info@LuminnovaHealth.com
CoVID-19 Infection Control Solutions
We have researched and sourced a number of measures that has enabled us to re-open our practice while keeping our commitment to keep our patients and team members as safe as possible.
Hypochlorous Acid - a non-toxic, non-irritating sanitizer which is 60-80 times the efficacy as bleach
Dry mist, ULV foggers
No-Touch Automatic Hand Sanitizers posted not just at the entrance but throughout our facility
UVC/Ozone Sterilizers for masks and other small items
Daily Temperature monitoring and recording for all team members and anyone visiting the practice
Use of telemedicine for all or part of the consultation process - wherever feasible
Transition to an online store to avoid browsing in our Skin Centre and Luminnova Health boutique
We have now made a number of these infection control products available to you for use at work, home, church, gyms and other places where these measures will significantly help to reduce the spread of CoVID-19.